Physician profile
Robert R Orr
NPI 1003809930
$11,748.73
in general payments reported to CMS, 2019-2025
59 companies · $4,310 in 2025
The $4,310 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,220 · 2020: $553 · 2021: $396 · 2022: $686 · 2023: $1,760 · 2024: $2,824 · 2025: $4,310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,439 · Education: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,439.25 |
| Education | $454.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,500.91 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,472.76 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,216.10 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $954.47 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $598.16 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Electromed, INC. | $481.93 | 2022-2025 | Smartvest |
| Insmed, INC. | $432.86 | 2020-2025 | Arikayce, Brinsupri |
| Harmony Biosciences LLC | $423.29 | 2021-2025 | Wakix |
| Medical Graphics Corporation | $410.35 | 2019 | |
| Jazz Pharmaceuticals INC. | $330.28 | 2023-2025 | |
| Baxter Healthcare | $301.59 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Mylan Specialty L.P. | $301.33 | 2019-2024 | Yupelri |
| Grifols USA, LLC | $292.92 | 2019-2025 | Prolastin-C Liquid |
| Genentech USA, INC. | $290.80 | 2019-2025 | Xolair |
| Sanofi-Aventis U.S. LLC | $253.73 | 2023-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $243.55 | 2025 | Ohtuvayre |
| Novartis Pharmaceuticals Corporation | $232.60 | 2019-2025 | |
| Philips North America LLC | $212.60 | 2019-2025 | Vest Therapy Und, (8874) Incourage |
| Actelion Pharmaceuticals US, INC. | $203.63 | 2019-2025 | Opsumit, Uptravi |
| Inspire Medical Systems, INC. | $140.54 | 2023-2025 | Inspire |
| United Therapeutics Corporation | $123.95 | 2019-2025 | Tyvaso, Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $123.16 | 2024-2025 | Glassia |
| Avadel Cns Pharmaceuticals, LLC | $115.97 | 2024-2025 | Lumryz |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.08 | 2021-2023 | Trulance, Xifaxan |
| Ani Pharmaceuticals, INC. | $98.66 | 2025 | Purified Cortrophin Gel |
| Sunovion Pharmaceuticals INC. | $74.66 | 2019-2020 | |
| Amgen INC. | $73.11 | 2025 | Tezspire |
| Pfizer INC. | $72.58 | 2020-2023 | |
| Inogen, INC. | $72.34 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Vifor Pharma, INC. | $66.41 | 2024 | Zemaira |
| Pulmonx Corporation | $53.02 | 2024-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Novo Nordisk INC | $51.33 | 2022 | |
| Viatris Specialty LLC | $50.57 | 2025 | Yupelri |
| Vapotherm INC | $44.11 | 2021 | |
| Lilly USA, LLC | $43.26 | 2025 | Zepbound, Mounjaro |
| Phadia US INC. | $40.26 | 2023-2024 | Immunocap |
| Abbott Laboratories | $35.45 | 2023 | Assurity, Eterna |
| Lucid Diagnostics INC. | $29.86 | 2022 | |
| Advanced Respiratory, INC | $28.83 | 2021 | |
| Merck Sharp & Dohme LLC | $25.30 | 2024 | Recarbrio, Zerbaxa |
| Boston Scientific Corporation | $25.09 | 2024 | |
| Nestle Healthcare Nutrition INC. | $24.98 | 2021 | |
| Eisai INC. | $19.94 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2019 | |
| Optos, INC. | $15.71 | 2021 | |
| Shire North American Group INC | $13.75 | 2019 | |
| Tactile Systems Technology INC | $12.95 | 2023 | Entre Plus, Flexitouch Plus |
12 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Orr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.